FYI | Jan 17 2024
This story features ACTINOGEN MEDICAL LIMITED, and other companies. For more info SHARE ANALYSIS: ACW
Research reports on ASX-listed companies, to download in full.
****
-Actinogen Medical ((ACW)) by Edison Research: https://www.fnarena.com/index.php/download-article/?n=6F597F30-F086-50B7-CE6D679E0943A40A
-AFT Pharmaceuticals ((AFP)) by Edison Research: https://www.fnarena.com/index.php/download-article/?n=6F75ECF8-E240-03CC-0BAF161241E25CB6
-Alkane Resources ((ALK)) by Edison Research: https://www.fnarena.com/index.php/download-article/?n=6F816A74-D0CD-587F-F6ACD5EADEE695FF
-Amaero International ((3DA)) by Research as a Service (RaaS): https://www.fnarena.com/index.php/download-article/?n=6FB3DDD8-09DD-DDFC-0AA736DC59D472E5
-Another (prior) research update: https://www.fnarena.com/index.php/download-article/?n=6FC21D92-956C-A906-EEA4DB1DC34D71B9
-Empire Energy Group ((EEG)) by Research as a Service (RaaS): https://www.fnarena.com/index.php/download-article/?n=6FCB8BE1-9471-8886-7F484D942238E97D
-Millennium Services Group ((MIL)) by Research as a Service (RaaS): https://www.fnarena.com/index.php/download-article/?n=6FD7D60B-D9B9-4BA8-28C622F812173A52
-Pioneer Credit ((PNC)) by Research as a Service (RaaS): https://www.fnarena.com/index.php/download-article/?n=6FE2F801-D3BA-7ED3-F40E54C12F1EBAA1
-Recce Pharmaceuticals ((RCE)) by Edison Research: https://www.fnarena.com/index.php/download-article/?n=6F816A74-D0CD-587F-F6ACD5EADEE695FF
Another (prior) update: https://www.fnarena.com/index.php/download-article/?n=6F9A0342-CF9D-DED5-6AF3B6CBB4E5AEC4
-Vection Technologies ((VR1)) by Edison Research: https://www.fnarena.com/index.php/download-article/?n=6FA4772E-EABA-65EB-35CA2F20B946C6B7
****
All of the above research reports have been produced without control or input from FNArena. These reports are redistributed as an extra service for investors, and solely for market transparency and information purposes.
Inclusion does not imply endorsement. This service does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. No guarantee is given that any of these reports are accurate or complete.
Investors should contact their personal adviser before making any investment decision. FNArena has the permission from respective publishers to redistribute these reports.
Investors should note reports may have been produced on request from companies involved. Reports are provided in full, including fine print and disclaimers.
ALWAYS DO YOUR OWN RESEARCH!
Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" – Warning this story contains unashamedly positive feedback on the service provided.
FNArena is proud about its track record and past achievements: Ten Years On
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: 3DA - AMAERO INTERNATIONAL LIMITED
For more info SHARE ANALYSIS: ACW - ACTINOGEN MEDICAL LIMITED
For more info SHARE ANALYSIS: AFP - AFT PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: ALK - ALKANE RESOURCES LIMITED
For more info SHARE ANALYSIS: EEG - EMPIRE ENERGY GROUP LIMITED
For more info SHARE ANALYSIS: MIL - MILLENNIUM SERVICES GROUP LIMITED
For more info SHARE ANALYSIS: PNC - PIONEER CREDIT LIMITED
For more info SHARE ANALYSIS: RCE - RECCE PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: VR1 - VECTION TECHNOLOGIES LIMITED